Skip to content

Access Total T3 33830Recalls & reported problems

Beckman Coulter, Inc. · The Access Total T3 assay is a paramagnetic particle, chemiluminescent immunoassay for the quantitative determination of triiodothyronine levels in human serum and plasma using the Access Immunoassay Systems. · Class 2

Adverse event reports
2
Deaths reported
0
Injuries reported
2
Recalls naming it
0

Summary

The FDA's MAUDE database contains 2 adverse event reports that list this exact device (DI 15099590227210), received between May 14, 2024 and May 14, 2024 — classified as 2 injuries.

The most frequently reported specific device problem is “High Test Results” (2 reports).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. How this data works · Data updated Oct 13, 2026.

Reports received per month

Nov 2023: 0 reportsDec 2023: 0 reportsJan 2024: 0 reportsFeb 2024: 0 reportsMar 2024: 0 reportsApr 2024: 0 reportsMay 2024: 2 reportsJun 2024: 0 reportsJul 2024: 0 reportsAug 2024: 0 reportsSep 2024: 0 reportsOct 2024: 0 reportsNov 2024: 0 reportsDec 2024: 0 reportsJan 2025: 0 reportsFeb 2025: 0 reportsMar 2025: 0 reportsApr 2025: 0 reportsMay 2025: 0 reportsJun 2025: 0 reportsJul 2025: 0 reportsAug 2025: 0 reportsSep 2025: 0 reportsOct 2025: 0 reportsNov 2025: 0 reportsDec 2025: 0 reportsJan 2026: 0 reportsFeb 2026: 0 reportsMar 2026: 0 reportsApr 2026: 0 reportsMay 2026: 0 reportsJun 2026: 0 reportsJul 2026: 0 reportsAug 2026: 0 reportsSep 2026: 0 reportsOct 2026: 0 reports2024202520262
Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

  • High Test Results2

Patient problems

  • Insufficient Information2

Recent adverse event reports

The 2 most recent of 2 reports, in the reporter's own words as published by the FDA.

  • InjuryMay 14, 2024High Test Results; High Test Results

    ON (B)(6) 2024 THE CUSTOMER REPORTED OBTAINING ERRONEOUSLY ELEVATED TOTAL T3 RESULTS FOR ONE PATIENT INVOLVING THE LABORATORY'S ACCESS 2 IMMUNOASSAY ANALYZER (SERIAL NUMBER (B)(6). THE TOTAL T3 CUSTOMER REFERENCE RANGES ARE 0.87-1.78 NG/ML. ON (B)(6) 2024, ONE SAMPLE WAS TESTED WITH A RESULT AT 1.95 NG/ML. THE SAMPLE WAS TESTED ON THE ROCHE ANALYZER WITH A TOTAL T3 RESULT AT 0.96 (NO UNIT PROVIDED). THE CUSTOMER REPORTED A DELAY IN PATIENT TREATMENT. THE CUSTOMER REPORTED THAT DOCTOR LOOKS AT TEST RESULTS AND PRESCRIBES MEDICATION ON THE SAME DAY. DUE TO THE QUESTIONED RESULTS, PATIENT SAMPLES ARE SENT TO AN EXTERNAL TESTING LABORATORY AND THE RESULTS ARE PROVIDED ONE DAY LATER. NO HARDWARE ERRORS WERE REPORTED IN CONJUNCTION WITH THIS EVENT. CALIBRATION PASSED ON 20MAR2024 WITH REAGENT LOT 338710 AND CALIBRATOR LOT 338395. NO QUALITY CONTROL DATA WAS PROVIDED. SERVICE WAS DISPATCHED. FIELD SERVICE ENGINEER (FSE) CHANGED REAGENT AND CALIBRATION AND USED HETEROPHILE BLOCKING TUBES BUT THE RESULTS WERE UNCHANGED. NO ISSUES WITH SAMPLES INTEGRITY WERE REPORTED BY THE CUSTOMER. NOTE: THE CUSTOMER REPORTED THAT THE ACCESS FREE T4 RESULTS FOR THIS PATIENT WERE ALSO QUESTIONED. A SECOND M

    Patient problems: Insufficient Information

    MAUDE report 19309697 ↗
  • InjuryMay 14, 2024High Test Results; High Test Results

    ON (B)(6) 2024 THE CUSTOMER REPORTED OBTAINING ERRONEOUSLY ELEVATED TOTAL T3 RESULTS FOR ONE PATIENT INVOLVING THE LABORATORY'S ACCESS 2 IMMUNOASSAY ANALYZER (SERIAL NUMBER (B)(6). THE CUSTOMER PROVIDED THE FOLLOWING RESULTS (THE TOTAL T3 CUSTOMER REFERENCE RANGES ARE 0.87-1.78 NG/ML). THE FIRST QUESTIONED SAMPLE TOTAL T3 RESULT FOR THIS PATIENT WAS 2.37 NG/ML ON (B)(6) 2023. THIS SAMPLE WAS TESTED ON AN ALTERNATE INSTRUMENT WITH A RESULT AT 0.64 (UNIT NOT PROVIDED). SAMPLE 2 TOTAL T3 RESULT WAS 3.05 NG/ML ON (B)(60 2024. THIS SAMPLE WAS TESTED ON AN ALTERNATE INSTRUMENT WITH A RESULT AT 0.84 (UNIT NOT PROVIDED). SAMPLE 3 TOTAL T3 RESULT WAS 2.43 NG/ML ON (B)(6) 2024. THIS SAMPLE WAS TESTED ON AN ALTERNATE INSTRUMENT WITH A RESULT AT 0.37 (UNIT NOT PROVIDED). SAMPLE 4 TOTAL T3 RESULT WAS 1.86 NG/ML ON (B)(6) 2024. THIS SAMPLE 4 WAS TESTED USING HETEROPHILE BLOCKING TUBE WITH A TOTAL T3 RESULT AT 1.89 NG/ML. THIS SAMPLE WAS ALSO TESTED ON AN ALTERNATE INSTRUMENT WITH A RESULT AT 0.52 (UNIT NOT PROVIDED). THE SAMPLE 5 RESULT WAS NOT QUESTIONED: TOTAL T3 RESULT WAS 0.8 NG/ML ON (B)(6) 2024. THIS SAMPLE 5 WAS TESTED ON AN ALTERNATE INSTRUMENT WITH A RESULT AT 0.75 (UNIT NOT PROVIDED).

    Patient problems: Insufficient Information

    MAUDE report 19309599 ↗

Other Radioimmunoassay, Total Triiodothyronine devices

All Radioimmunoassay, Total Triiodothyronine devices →

Sources: FDA GUDID, MAUDE and Medical Device Recalls via openFDA. openFDA data is not validated for clinical or regulatory use.